Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Motivation fMRI Study
NCT01722071Phase 2Completed
- Start
- Oct 2012
- Primary completion
- Sep 2013
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin nasal spray in substance dependence (2 arms). Primary endpoint: Change in BOLD Activity Between Placebo and Oxytocin Treatment at Day 30. Started Oct 2012; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
substance dependence
Beyond the preview
Go deeper on NCT01722071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01722071.